API
< Back to all clusters
[BUSINESS] · Brazil · 2 sources

started · updated

Brazilian court orders health insurer to provide multiple sclerosis medication

A court in Rio Grande do Norte has ordered a health insurance provider to supply the medication Kesimpta 20 mg to a patient diagnosed with relapsing multiple sclerosis. The ruling, issued by Judge Valéria Maria Lacerda of the 1st Civil Court of Natal, also requires the company to pay R$ 6,000 in moral damages.

The insurer had previously denied coverage, arguing that the drug was not included in the National Supplementary Health Agency (ANS) list and that alternative first-line therapies were available. The company further claimed that providing the treatment could jeopardize the economic and financial stability of the contract.

In her decision, the judge noted that the relationship is governed by the Consumer Defense Code. She ruled that the absence of a medication from the ANS list does not alone justify a refusal of coverage, especially when medical reports provide technical justification for the urgency and specific necessity of a treatment. The court found that the alternative suggested by the insurer, Natalizumab, was not suitable for the patient's specific clinical conditions.

Entities

Natal · National Supplementary Health Agency · Rio Grande do Norte · Valéria Maria Lacerda